Financhill
Buy
77

HQY Quote, Financials, Valuation and Earnings

Last price:
$98.34
Seasonality move :
8.45%
Day range:
$94.34 - $98.05
52-week range:
$65.01 - $115.59
Dividend yield:
0%
P/E ratio:
89.59x
P/S ratio:
7.22x
P/B ratio:
3.99x
Volume:
822.4K
Avg. volume:
1.1M
1-year change:
28.74%
Market cap:
$8.4B
Revenue:
$1.2B
EPS (TTM):
$1.09

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
HQY
HealthEquity
$322.3M $0.82 12.21% 147.57% $110.93
HSTM
HealthStream
$74.9M $0.17 4.16% 25% $34.50
SDGR
Schrodinger
$54.6M -$0.81 9.93% -8.11% $31.78
SLP
Simulations Plus
$21.9M $0.26 23.35% 85.71% $46.60
VEEV
Veeva Systems
$728.4M $1.74 11.93% 76.63% $262.35
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
HQY
HealthEquity
$97.65 $110.93 $8.4B 89.59x $0.00 0% 7.22x
HSTM
HealthStream
$27.57 $34.50 $841.6M 43.76x $0.03 0.42% 2.88x
SDGR
Schrodinger
$23.36 $31.78 $1.7B -- $0.00 0% 7.38x
SLP
Simulations Plus
$30.75 $46.60 $618.4M 87.86x $0.06 0.78% 7.95x
VEEV
Veeva Systems
$241.60 $262.35 $39.3B 55.80x $0.00 0% 14.52x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
HQY
HealthEquity
33.31% 2.484 11.05% 2.65x
HSTM
HealthStream
-- 1.022 -- 1.19x
SDGR
Schrodinger
-- 1.761 -- 3.30x
SLP
Simulations Plus
-- 2.150 -- 3.54x
VEEV
Veeva Systems
-- 0.472 -- 4.44x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
HQY
HealthEquity
$189M $44.3M 3.11% 4.59% 14.5% $62.2M
HSTM
HealthStream
$48M $4.4M 5.39% 5.39% 5.96% $18.2M
SDGR
Schrodinger
$31.1M -$50.9M -43.06% -43.06% -85.46% $143.5M
SLP
Simulations Plus
$13.1M $2.7M 3.97% 3.97% 12.09% $4.7M
VEEV
Veeva Systems
$539.9M $188.4M 13.71% 13.71% 26.14% $69.5M

HealthEquity vs. Competitors

  • Which has Higher Returns HQY or HSTM?

    HealthStream has a net margin of 8.46% compared to HealthEquity's net margin of 5.9%. HealthEquity's return on equity of 4.59% beat HealthStream's return on equity of 5.39%.

    Company Gross Margin Earnings Per Share Invested Capital
    HQY
    HealthEquity
    60.63% $0.30 $3.2B
    HSTM
    HealthStream
    65.32% $0.14 $362.8M
  • What do Analysts Say About HQY or HSTM?

    HealthEquity has a consensus price target of $110.93, signalling upside risk potential of 13.6%. On the other hand HealthStream has an analysts' consensus of $34.50 which suggests that it could grow by 25.14%. Given that HealthStream has higher upside potential than HealthEquity, analysts believe HealthStream is more attractive than HealthEquity.

    Company Buy Ratings Hold Ratings Sell Ratings
    HQY
    HealthEquity
    9 1 0
    HSTM
    HealthStream
    2 3 0
  • Is HQY or HSTM More Risky?

    HealthEquity has a beta of 0.455, which suggesting that the stock is 54.483% less volatile than S&P 500. In comparison HealthStream has a beta of 0.501, suggesting its less volatile than the S&P 500 by 49.941%.

  • Which is a Better Dividend Stock HQY or HSTM?

    HealthEquity has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. HealthStream offers a yield of 0.42% to investors and pays a quarterly dividend of $0.03 per share. HealthEquity pays -- of its earnings as a dividend. HealthStream pays out 17.01% of its earnings as a dividend. HealthStream's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios HQY or HSTM?

    HealthEquity quarterly revenues are $311.8M, which are larger than HealthStream quarterly revenues of $73.5M. HealthEquity's net income of $26.4M is higher than HealthStream's net income of $4.3M. Notably, HealthEquity's price-to-earnings ratio is 89.59x while HealthStream's PE ratio is 43.76x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for HealthEquity is 7.22x versus 2.88x for HealthStream. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    HQY
    HealthEquity
    7.22x 89.59x $311.8M $26.4M
    HSTM
    HealthStream
    2.88x 43.76x $73.5M $4.3M
  • Which has Higher Returns HQY or SDGR?

    Schrodinger has a net margin of 8.46% compared to HealthEquity's net margin of -100.43%. HealthEquity's return on equity of 4.59% beat Schrodinger's return on equity of -43.06%.

    Company Gross Margin Earnings Per Share Invested Capital
    HQY
    HealthEquity
    60.63% $0.30 $3.2B
    SDGR
    Schrodinger
    52.26% -$0.82 $373.5M
  • What do Analysts Say About HQY or SDGR?

    HealthEquity has a consensus price target of $110.93, signalling upside risk potential of 13.6%. On the other hand Schrodinger has an analysts' consensus of $31.78 which suggests that it could grow by 36.04%. Given that Schrodinger has higher upside potential than HealthEquity, analysts believe Schrodinger is more attractive than HealthEquity.

    Company Buy Ratings Hold Ratings Sell Ratings
    HQY
    HealthEquity
    9 1 0
    SDGR
    Schrodinger
    6 2 0
  • Is HQY or SDGR More Risky?

    HealthEquity has a beta of 0.455, which suggesting that the stock is 54.483% less volatile than S&P 500. In comparison Schrodinger has a beta of 1.838, suggesting its more volatile than the S&P 500 by 83.79%.

  • Which is a Better Dividend Stock HQY or SDGR?

    HealthEquity has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Schrodinger offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. HealthEquity pays -- of its earnings as a dividend. Schrodinger pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios HQY or SDGR?

    HealthEquity quarterly revenues are $311.8M, which are larger than Schrodinger quarterly revenues of $59.6M. HealthEquity's net income of $26.4M is higher than Schrodinger's net income of -$59.8M. Notably, HealthEquity's price-to-earnings ratio is 89.59x while Schrodinger's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for HealthEquity is 7.22x versus 7.38x for Schrodinger. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    HQY
    HealthEquity
    7.22x 89.59x $311.8M $26.4M
    SDGR
    Schrodinger
    7.38x -- $59.6M -$59.8M
  • Which has Higher Returns HQY or SLP?

    Simulations Plus has a net margin of 8.46% compared to HealthEquity's net margin of 13.7%. HealthEquity's return on equity of 4.59% beat Simulations Plus's return on equity of 3.97%.

    Company Gross Margin Earnings Per Share Invested Capital
    HQY
    HealthEquity
    60.63% $0.30 $3.2B
    SLP
    Simulations Plus
    58.52% $0.15 $189.5M
  • What do Analysts Say About HQY or SLP?

    HealthEquity has a consensus price target of $110.93, signalling upside risk potential of 13.6%. On the other hand Simulations Plus has an analysts' consensus of $46.60 which suggests that it could grow by 51.55%. Given that Simulations Plus has higher upside potential than HealthEquity, analysts believe Simulations Plus is more attractive than HealthEquity.

    Company Buy Ratings Hold Ratings Sell Ratings
    HQY
    HealthEquity
    9 1 0
    SLP
    Simulations Plus
    6 1 0
  • Is HQY or SLP More Risky?

    HealthEquity has a beta of 0.455, which suggesting that the stock is 54.483% less volatile than S&P 500. In comparison Simulations Plus has a beta of 1.101, suggesting its more volatile than the S&P 500 by 10.072%.

  • Which is a Better Dividend Stock HQY or SLP?

    HealthEquity has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Simulations Plus offers a yield of 0.78% to investors and pays a quarterly dividend of $0.06 per share. HealthEquity pays -- of its earnings as a dividend. Simulations Plus pays out 48.18% of its earnings as a dividend. Simulations Plus's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios HQY or SLP?

    HealthEquity quarterly revenues are $311.8M, which are larger than Simulations Plus quarterly revenues of $22.4M. HealthEquity's net income of $26.4M is higher than Simulations Plus's net income of $3.1M. Notably, HealthEquity's price-to-earnings ratio is 89.59x while Simulations Plus's PE ratio is 87.86x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for HealthEquity is 7.22x versus 7.95x for Simulations Plus. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    HQY
    HealthEquity
    7.22x 89.59x $311.8M $26.4M
    SLP
    Simulations Plus
    7.95x 87.86x $22.4M $3.1M
  • Which has Higher Returns HQY or VEEV?

    Veeva Systems has a net margin of 8.46% compared to HealthEquity's net margin of 27.14%. HealthEquity's return on equity of 4.59% beat Veeva Systems's return on equity of 13.71%.

    Company Gross Margin Earnings Per Share Invested Capital
    HQY
    HealthEquity
    60.63% $0.30 $3.2B
    VEEV
    Veeva Systems
    74.89% $1.18 $5.8B
  • What do Analysts Say About HQY or VEEV?

    HealthEquity has a consensus price target of $110.93, signalling upside risk potential of 13.6%. On the other hand Veeva Systems has an analysts' consensus of $262.35 which suggests that it could grow by 8.59%. Given that HealthEquity has higher upside potential than Veeva Systems, analysts believe HealthEquity is more attractive than Veeva Systems.

    Company Buy Ratings Hold Ratings Sell Ratings
    HQY
    HealthEquity
    9 1 0
    VEEV
    Veeva Systems
    12 10 1
  • Is HQY or VEEV More Risky?

    HealthEquity has a beta of 0.455, which suggesting that the stock is 54.483% less volatile than S&P 500. In comparison Veeva Systems has a beta of 0.964, suggesting its less volatile than the S&P 500 by 3.645%.

  • Which is a Better Dividend Stock HQY or VEEV?

    HealthEquity has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Veeva Systems offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. HealthEquity pays -- of its earnings as a dividend. Veeva Systems pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios HQY or VEEV?

    HealthEquity quarterly revenues are $311.8M, which are smaller than Veeva Systems quarterly revenues of $720.9M. HealthEquity's net income of $26.4M is lower than Veeva Systems's net income of $195.6M. Notably, HealthEquity's price-to-earnings ratio is 89.59x while Veeva Systems's PE ratio is 55.80x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for HealthEquity is 7.22x versus 14.52x for Veeva Systems. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    HQY
    HealthEquity
    7.22x 89.59x $311.8M $26.4M
    VEEV
    Veeva Systems
    14.52x 55.80x $720.9M $195.6M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Unity Software a Buy Now?
Is Unity Software a Buy Now?

Unity Software (NYSE:U) is the company behind the popular Unity…

Will Uber Stock 5X?
Will Uber Stock 5X?

Uber (NYSE:UBER) has generated extremely strong returns for its investors…

How High Will Bloom Energy Stock Go?
How High Will Bloom Energy Stock Go?

Bloom Energy (NYSE:BE) has seen its shares surge by more…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 38x

Buy
71
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
46
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
59
RGC alert for May 16

Regencell Bioscience Holdings [RGC] is down 4.18% over the past day.

Buy
89
BOOT alert for May 16

Boot Barn Holdings [BOOT] is up 1.14% over the past day.

Sell
43
FI alert for May 16

Fiserv [FI] is up 4.73% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock